Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin
Clinical trial NCT01571414 · COMPLETED
Trial details
- NCT number
- NCT01571414
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-05-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.